Markets:

Overview

News

Currencies

International

Treasuries

Zoetis (NY:ZTS)

126.85 +1.18 (+0.94%)

Official Closing Price Updated: 7:00 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

P/E Ratio Insights for Zoetis ↗

May 02, 2025

Via Benzinga

1 Safe-and-Steady Stock to Target This Week and 2 to Be Wary Of

May 02, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off ↗

April 26, 2025

Via The Motley Fool

1 Superstar Dividend Growth Stock to Buy if the Market Crashes ↗

April 26, 2025

Investors have been waiting nearly a decade to score a good deal on this healthcare star.

Via The Motley Fool

Topics Economy Government

A Once-in-a-Decade Opportunity: 3 Magnificent Stocks Down Between 40% and 73% to Buy Right Now ↗

April 19, 2025

Via The Motley Fool

Looking Into Zoetis's Recent Short Interest ↗

April 16, 2025

Via Benzinga

3 Magnificent Stocks to Buy That Are Near 52-Week Lows ↗

April 19, 2025

Via The Motley Fool

Topics Economy Government

2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 to Be Wary Of

April 17, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

April 10, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Eli Lilly (NYSE:LLY) and its peers.

Via StockStory

Topics Artificial Intelligence Intellectual Property

Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

April 08, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Organon (NYSE:OGN) and the best and worst...

Via StockStory

Topics Artificial Intelligence Intellectual Property

This Magnificent Dividend Stock Has Increased Its Payouts by 500% in 10 Years ↗

April 03, 2025

Via The Motley Fool

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

April 02, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Collegium Pharmaceutical...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Zoetis' Stock Is About as Cheap as It's Ever Been. 1 Thing to Know Before You Buy. ↗

March 27, 2025

Via The Motley Fool

Zoetis to Host Webcast and Conference Call on First Quarter 2025 Financial Results

March 27, 2025

From Zoetis Inc.

Via Business Wire

Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks

March 27, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Pfizer (NYSE:PFE) and its peers.

Via StockStory

Topics Artificial Intelligence Intellectual Property

Stop Chasing Returns And Start Getting Rising Dividends With These 10 Blue Chip Stocks ↗

March 23, 2025

Instead of chasing returns, investors can start building long-term passive income through dividend growth stocks.

Via Talk Markets

Topics Stocks / Equities

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

March 21, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Royalty Pharma (NASDAQ:RPRX)...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

March 18, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how pharmaceuticals stocks fared in Q4, starting with Elanco...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks

March 14, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at branded pharmaceuticals stocks, starting...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks

March 04, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, including Corcept (NASDAQ:CORT) and its peers.

Via StockStory

Topics Artificial Intelligence Intellectual Property

Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

March 04, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bristol-Myers Squibb (NYSE:BMY) and the best...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Zoetis (ZTS): Buy, Sell, or Hold Post Q4 Earnings?

March 03, 2025

Over the past six months, Zoetis’s shares (currently trading at $166) have posted a disappointing 9.6% loss, well below the S&P 500’s 7.6% gain. This was partly driven by its softer quarterly results...

Via StockStory

Topics Stocks

Rule Breaker Investing: Pet Perks, Vol. 2 ↗

February 24, 2025

Little things can make a big difference.

Via The Motley Fool

Discover the top S&P500 movers in Monday's pre-market session. ↗

February 24, 2025

The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.

Via Chartmill

A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend Stock Down 36% to Double Up on Right Now ↗

February 23, 2025

Via The Motley Fool

Topics Stocks

2 Healthcare Stocks with Big Upside and 1 to Skip

February 21, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

Zoetis to Participate in Upcoming Investor Conferences

February 20, 2025

From Zoetis Inc.

Via Business Wire

Rule Breaker Investing Stock Stories, Vol. 10: Frosty Campfire, Fiery Stocks ↗

February 19, 2025

Every stock tells a story; it takes humans to find the meaning in it.

Via The Motley Fool

Love, Money, and Stocks ↗

February 18, 2025

Via The Motley Fool

Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗

February 18, 2025

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the S&P500 stocks with an unusual volume in today's session.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.